Treatment Options in Osteoporosis Across the Spectrum of Fracture Risk
Browse by: | Sort by: |
Chair
Elaine Yu, MD
Massachusetts General Hospital, Boston, MA
Welcome and Introductions
Treatment Options for Individuals at Moderate Fracture Risk
Ian Reid, FRACP
University of Auckland, Auckland, New Zealand
Live Moderated Q&A
Transitions in Osteoporosis Pharmacotherapy
Benjamin Leder, MD
Massachusetts General Hospital, Boston, MA
Live Moderated Q&A
Sclerostin Inhibition for the Treatment of Osteoporosis
Suzanne Jan De Beur, MD
Johns Hopkins University School of Medicine, Baltimore, MD
Live Moderated Q&A and Session Closing
Available